SINGAPORE, Dec. 9, 2014 /PRNewswire/ - Zecotek
Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I), a developer of
leading-edge photonics technologies for medical, industrial and
scientific markets, today announced that the Japanese Patent Office
has issued a patent for its Micro-channel Avalanche Photodiode
(MAPD) silicon photomultiplier. The Company continues to
secure important intellectual property related to key elements of a
high performance positron emission tomography (PET) medical
scanner, high energy physics (CERN), and retrofit industrial
imaging sectors. Strengthening its worldwide patent portfolio
specific to imaging technology and associated components remains a
high priority.
"Our MAPD silicon photomultipliers are now patented in
Japan, the United States, Russia, South
Korea, Singapore and
China, with patents pending in
other countries," said Dr. A.F.
Zerrouk, Chairman, President, and CEO of Zecotek Photonics
Inc. "We will continue to secure intellectual property for
those components, such as the MAPDs and LFS scintillation crystals,
used in next generation PET medical scanners and high energy
physics."
The MAPD silicon photomultipliers are manufactured under
contract by the National NanoFab Center in South Korea.
Zecotek is scheduled to show case the high timing resolution, low
dark counts, low over voltage and high photo-detection-efficiency
of MAPD arrays in April 2015. The
MAPD array is a match to the cost competitive, high performance LFS
array for integrated detection solutions. Zecotek is working
with major OEMs to prepare for the adoption of its MAPD array as
the industry moves toward introducing Time of Flight PET medical
scanners as a transition from photomultiplier tubes. In addition,
the MAPD's ability to exhibit very high linearity and very high
radiation hardness makes it the prime candidate for CERN's extreme
energies in the new generations of the Large Hadron Collider.
Zecotek's patented MAPD-3N is a design upgrade of the previously
announced MAPD. It offers significant performance-cost advantages
over competing photomultiplier tubes (PMT) and other solid-state,
silicon based photo-detectors. Its good recovery time, unique
radiation hardness and display of the highest possible linearity
make it a prime component for the improved detector designs
required in the next crucial phase of high energy experiments at
CERN. Its low manufacturing cost, excellent timing resolution and
Photon Detection Efficiency are key characteristics for the new
configurations of high resolution PET (Positron Emission
Tomography) scanners.
The MAPD-3N is supplied to customers through Zecotek Imaging
Systems Pte. Ltd., Singapore, a
wholly owned subsidiary of Zecotek Photonics Inc.
About Zecotek
Zecotek Photonics Inc (TSX-V: ZMS;
Frankfurt: W1I) is a photonics technology company developing
high-performance scintillation crystals, photo detectors, positron
emission tomography scanning technologies, 3D auto-stereoscopic
displays, and lasers for applications in medical, high-tech and
industrial sectors. Founded in 2004, Zecotek operates three
divisions: Imaging Systems, Laser Systems and 3D Display Systems
with labs located in Canada,
Korea, Russia, Singapore and U.S.A. The management team is focused on
building shareholder value by commercializing over 50 patented and
patent pending novel photonic technologies directly and through
strategic alliances and joint ventures with leading industry
partners including Hamamatsu Photonics (Japan), the European Organization for Nuclear
Research (Switzerland), Beijing
Opto-Electronics Technology Co. Ltd. (China), NuCare Medical Systems (South Korea), the University of Washington (United States), and National NanoFab Center
(South Korea). For more
information visit www.zecotek.com, follow @zecotek on Twitter and
"like" us in Facebook at www.facebook.com/zecotek.
This press release may contain forward-looking statements
that are based on management's expectations, estimates, projections
and assumptions. These statements are not guarantees of future
performance and involve certain risks and uncertainties, which are
difficult to predict. Therefore, actual future results and trends
may differ materially from what may have been stated.
The TSX Venture 50® are the top 10 companies listed on the TSX
Venture Exchange, in each of five major industry sectors – mining,
oil & gas, technology & life sciences, diversified
industries and clean technology – based on a ranking formula with
equal weighting given to return on investment, market cap growth,
trading volume and analyst coverage. All data was as of
December 31, 2013.
Neither the TSX Venture Exchange nor its Regulation Service
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of the content of this news release. If you would like to
receive news from Zecotek in the future please visit the corporate
website at www.zecotek.com.
SOURCE Zecotek Photonics Inc.
